i disagree completely.

i'm pretty sure SK was one of the big supporters / drivers into cancer indications, including TNBC - one of our biggest potential markets. someone else can correct me if i'm wrong, but i know he played an outsized role.

Second, i remember the call when he disclosed that he and board had a search committee to replace Nader - well before he was ultimately replaced. The reason they didn't is because they couldn't find a suitable replacement - which i believe, given how long it took to find Cyrus. so he has not been a mindless pawn to NP.

lastly, i view him as one of the most impressive members of the team - and he has the the most history with our drug, providing continuity to Cyrus.

there is a reason why he wasn't shown the door with NP - and you can bet they spent a lot of time thinking through the team at that point in time. thankfully that decision will continue to rest with the company - and i will bet they believe as i do that he's an asset to the company.